Combining a peptide vaccine with high-dose interleukin-2.
Chapman
Paul B
PB
D019496:Cancer Vaccines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D008213:Lymphocyte Activation; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D022223:Vaccines, Subunit / Q000008:administration & dosage
D019496:Cancer Vaccines; D007376:Interleukin-2; D022223:Vaccines, Subunit